STOCK TITAN

Embecta Corp Financials

EMBC
Trailing 12 months to June 30, 2026
Revenue $1.0B -7.6% YoY
Net Income $87.5M +4.7% YoY
EPS (Diluted) $1.47 +3.5% YoY
Free Cash Flow $164.6M +24.4% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD FYE September

Embecta Corp (EMBC) reported $1.0B in revenue over the twelve months to Jun 30, 2026, down 7.6% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI EMBC FY2025

Debt-heavy balance sheet is being reduced while cash conversion rebounds, even as revenue contracts and operating margins recover.

Revenue fell from $1.12B in FY2024 to $1.08B in FY2025, so the earnings improvement did not depend on volume expansion. Operating margin widened to 22.4% even as gross margin narrowed to 62.6%, pointing to cost reduction below gross profit rather than stronger product-level margin.

Free cash flow rose from $20M in FY2024 to $182M in FY2025, showing that the earnings rebound converted into cash rather than remaining an accrual effect. Capital spending was $9M against $192M of operating cash flow, so reinvestment consumed a modest share of internally generated cash.

FY2025 liabilities of $1.74B exceeded assets of $1.09B, leaving negative equity as the central solvency structure. Long-term debt declined from $1.60B in FY2022 to $1.39B in FY2025, indicating that cash generation is being accompanied by balance-sheet deleveraging.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 55 / 100
Financial Health Score 55/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Embecta Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
79

Embecta Corp has an operating margin of 22.4%, meaning the company retains $22 of operating profit per $100 of revenue. This strong profitability earns a score of 79/100, reflecting efficient cost management and pricing power. This is up from 14.8% the prior year.

Growth
26

Embecta Corp's revenue declined 3.8% year-over-year, from $1.1B to $1.1B. This contraction results in a growth score of 26/100.

Leverage
14
Liquidity
67

With a current ratio of 2.41, Embecta Corp holds $2.41 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 67/100.

Cash Flow
66

Embecta Corp converts 16.9% of revenue into free cash flow ($182.4M). This strong cash generation earns a score of 66/100.

Returns
80
Altman Z-Score Distress
1.66

Embecta Corp scores 1.66, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
6/9

Embecta Corp passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
2.01x

For every $1 of reported earnings, Embecta Corp generates $2.01 in operating cash flow ($191.7M OCF vs $95.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.1B
YoY-3.8%
5Y CAGR-0.1%

Embecta Corp generated $1.1B in revenue in fiscal year 2025. This represents a decrease of 3.8% from the prior year.

EBITDA
$282.8M
YoY+39.3%
5Y CAGR-11.6%

Embecta Corp's EBITDA was $282.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 39.3% from the prior year.

Net Income
$95.4M
YoY+21.8%
5Y CAGR-25.9%

Embecta Corp reported $95.4M in net income in fiscal year 2025. This represents an increase of 21.8% from the prior year.

EPS (Diluted)
$1.62
YoY+20.9%
5Y CAGR-26.4%

Embecta Corp earned $1.62 per diluted share (EPS) in fiscal year 2025. This represents an increase of 20.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$182.4M
YoY+816.6%
5Y CAGR-16.8%

Embecta Corp generated $182.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 816.6% from the prior year.

Cash & Debt
$225.5M
YoY-15.7%

Embecta Corp held $225.5M in cash against $1.4B in long-term debt as of fiscal year 2025.

Dividends Per Share
$0.60
YoY0.0%

Embecta Corp paid $0.60 per share in dividends in fiscal year 2025. That is unchanged from the prior year.

Shares Outstanding
59M
YoY+0.7%

Embecta Corp had 59M shares outstanding in fiscal year 2025. This represents an increase of 0.7% from the prior year.

Margins & Returns

Gross Margin
62.6%
YoY-2.8pp
5Y CAGR-7.6pp

Embecta Corp's gross margin was 62.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 2.8 percentage points from the prior year.

Operating Margin
22.4%
YoY+7.6pp
5Y CAGR-22.4pp

Embecta Corp's operating margin was 22.4% in fiscal year 2025, reflecting core business profitability. This is up 7.6 percentage points from the prior year.

Net Margin
8.8%
YoY+1.9pp
5Y CAGR-30.6pp

Embecta Corp's net profit margin was 8.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.9 percentage points from the prior year.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

R&D Spending
$37.3M
YoY-52.7%
5Y CAGR-9.5%

Embecta Corp invested $37.3M in research and development in fiscal year 2025. This represents a decrease of 52.7% from the prior year.

Capital Expenditures
$9.3M
YoY-41.1%
5Y CAGR-26.0%

Embecta Corp invested $9.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 41.1% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

EMBC Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EMBC quarterly income statement
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Revenue$271.7M+22.5%$221.8M-15.1%$261.2M-1.1%$264.0M-10.7%$295.5M+14.1%$259.0M-1.1%$261.9M-8.5%$286.1M
Cost of Revenue$118.4M+26.0%$94.0M-5.5%$99.5M-5.7%$105.5M+7.2%$98.4M+3.7%$94.9M-9.4%$104.8M-6.7%$112.3M
Gross Profit$153.3M+20.0%$127.8M-21.0%$161.7M+2.0%$158.5M-19.6%$197.1M+20.1%$164.1M+4.5%$157.1M-9.6%$173.8M
R&D Expenses$5.6M+3.7%$5.4M+17.4%$4.6M0.0%$4.6M+4.5%$4.4M-45.0%$8.0M-60.6%$20.3M+2.5%$19.8M
SG&A Expenses$78.6M+3.1%$76.2M-1.8%$77.6M-10.7%$86.9M+3.0%$84.4M+6.0%$79.6M-1.8%$81.1M-16.2%$96.8M
Operating Income$48.7M+39.1%$35.0M-58.0%$83.3M+47.4%$56.5M-39.9%$94.0M+49.4%$62.9M+119.2%$28.7M+9.5%$26.2M
Income Tax$6.5M-52.2%$13.6M-8.1%$14.8M+469.2%$2.6M-90.3%$26.7M+117.1%$12.3M+1857.1%-$700K+96.8%-$21.6M
Net Income$21.1M+614.6%-$4.1M-109.3%$44.1M+67.0%$26.4M-42.0%$45.5M+93.6%$23.5M$0-100.0%$14.6M
EPS (Diluted)$0.36+614.3%-$0.07-109.5%$0.74+68.2%$0.44-43.6%$0.78+95.0%$0.40$0.00-100.0%$0.24

Not reported in any period shown, so not listed: Interest Expense.

EMBC Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EMBC quarterly balance sheet
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Total Assets$1.3B+22.9%$1.0B-3.2%$1.1B-2.5%$1.1B-5.7%$1.2B+3.3%$1.1B-2.5%$1.1B-10.6%$1.3B
Current Assets$705.1M+16.0%$608.1M-2.0%$620.2M-1.8%$631.4M-7.4%$681.5M+5.9%$643.4M-3.6%$667.2M-12.3%$761.0M
Cash & Equivalents$214.7M+16.1%$184.9M-8.1%$201.3M-10.7%$225.5M-2.2%$230.6M+10.2%$209.3M-0.3%$210.0M-21.5%$267.5M
Inventory$214.2M+11.2%$192.6M+5.9%$181.8M+1.8%$178.6M-6.0%$189.9M+12.2%$169.2M+0.1%$169.1M-1.4%$171.5M
Accounts Receivable$182.2M+23.9%$147.1M-7.6%$159.2M+9.3%$145.6M-20.4%$182.8M-1.5%$185.6M+2.6%$180.9M-6.3%$193.0M
Goodwill$39.9M+159.1%$15.4M0.0%$15.4M0.0%$15.4M0.0%$15.4M-0.6%$15.5M0.0%$15.5M-0.6%$15.6M
Total Liabilities$1.9B+13.4%$1.7B-1.3%$1.7B-3.7%$1.7B-4.7%$1.8B-1.6%$1.9B-3.2%$1.9B-5.2%$2.0B
Current Liabilities$419.8M+69.8%$247.3M+5.4%$234.7M-10.2%$261.5M-5.1%$275.5M+6.2%$259.3M-13.0%$298.2M-20.3%$374.0M
Long-Term Debt$1.3B-0.1%$1.3B-2.7%$1.4B-2.6%$1.4B-4.8%$1.5B-3.3%$1.5B-1.7%$1.5B-2.0%$1.6B
Total Equity-$612.7M+2.1%-$626.1M-2.1%-$613.1M+5.8%-$650.6M+2.8%-$669.6M+9.0%-$736.2M+4.2%-$768.8M-4.1%-$738.3M
Retained Earnings-$404.3M+4.8%-$424.7M-3.3%-$411.1M+7.7%-$445.6M+2.5%-$457.1M+7.4%-$493.5M+2.8%-$507.9M-1.9%-$498.6M

EMBC Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

EMBC quarterly cash flow statement
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Operating Cash Flow$41.8M+34.4%$31.1M+80.8%$17.2M-79.5%$84.0M+3.4%$81.2M+155.3%$31.8M+700.0%-$5.3M-119.9%$26.6M
Capital Expenditures$1.1M+120.0%$500K-16.7%$600K-91.8%$7.3M+1725.0%$400K+300.0%$100K-93.3%$1.5M$0
Free Cash Flow$40.7M+33.0%$30.6M+84.3%$16.6M-78.4%$76.7M-5.1%$80.8M+154.9%$31.7M+566.2%-$6.8M-125.6%$26.6M
Investing Cash Flow-$129.5M-25800.0%-$500K-105.3%$9.5M+230.1%-$7.3M-1725.0%-$400K-300.0%-$100K+93.3%-$1.5M$0
Financing Cash Flow$112.4M+370.8%-$41.5M+19.6%-$51.6M+36.8%-$81.6M-30.4%-$62.6M-67.8%-$37.3M+17.5%-$45.2M-23.5%-$36.6M
Dividends Paid$600K-93.3%$8.9M0.0%$8.9M+1.1%$8.8M+1.1%$8.7M0.0%$8.7M-1.1%$8.8M+1.1%$8.7M

Not reported in any period shown, so not listed: Share Buybacks.

EMBC Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

EMBC quarterly financial ratios
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Gross Margin56.4%-1.2pp57.6%-4.3pp61.9%+1.9pp60.0%-6.7pp66.7%+3.3pp63.4%+3.4pp60.0%-0.8pp60.8%
Operating Margin17.9%+2.1pp15.8%-16.1pp31.9%+10.5pp21.4%-10.4pp31.8%+7.5pp24.3%+13.3pp11.0%+1.8pp9.2%
Net Margin7.8%+9.6pp-1.8%-18.7pp16.9%+6.9pp10.0%-5.4pp15.4%+6.3pp9.1%+9.1pp0.0%-5.1pp5.1%
Return on Assets1.7%+2.1pp-0.4%-4.5pp4.2%+1.7pp2.4%-1.5pp3.9%+1.8pp2.1%+2.1pp0.0%-1.1pp1.1%
Current Ratio1.68-0.8x2.46-0.2x2.64+0.2x2.41-0.1x2.470.0x2.48+0.2x2.24+0.2x2.03
FCF Margin15.0%+1.2pp13.8%+7.4pp6.4%-22.7pp29.0%+1.7pp27.3%+15.1pp12.2%+14.8pp-2.6%-11.9pp9.3%

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity.

Note: Shareholder equity is negative (-$650.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Frequently Asked Questions

What is Embecta Corp's annual revenue?

Embecta Corp (EMBC) reported $1.1B in total revenue for fiscal year 2025. This represents a -3.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Embecta Corp's revenue growing?

Embecta Corp (EMBC) revenue declined by 3.8% year-over-year, from $1.1B to $1.1B in fiscal year 2025.

Is Embecta Corp profitable?

Yes, Embecta Corp (EMBC) reported a net income of $95.4M in fiscal year 2025, with a net profit margin of 8.8%.

Embecta Corp (EMBC) reported diluted earnings per share of $1.62 for fiscal year 2025. This represents a 20.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Embecta Corp (EMBC) had EBITDA of $282.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Embecta Corp (EMBC) had $225.5M in cash and equivalents against $1.4B in long-term debt.

Embecta Corp (EMBC) had a gross margin of 62.6% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Embecta Corp (EMBC) had an operating margin of 22.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Embecta Corp (EMBC) had a net profit margin of 8.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Embecta Corp (EMBC) paid $0.60 per share in dividends during fiscal year 2025.

Embecta Corp (EMBC) generated $182.4M in free cash flow during fiscal year 2025. This represents a 816.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Embecta Corp (EMBC) generated $191.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Embecta Corp (EMBC) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.

Embecta Corp (EMBC) invested $9.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Embecta Corp (EMBC) invested $37.3M in research and development during fiscal year 2025.

Embecta Corp (EMBC) had 59M shares outstanding as of fiscal year 2025.

Embecta Corp (EMBC) had a current ratio of 2.41 as of fiscal year 2025, which is generally considered healthy.

Embecta Corp (EMBC) had a return on assets of 8.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Embecta Corp (EMBC) has negative shareholder equity of -$650.6M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Embecta Corp (EMBC) has an Altman Z-Score of 1.66, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Embecta Corp (EMBC) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Embecta Corp (EMBC) has an earnings quality ratio of 2.01x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Embecta Corp (EMBC) scores 55 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top